Sadeq, Refaat, et al. “Endogenous IFNγ in Chronic HCV Genotype 4 Patients Treated With PEG-IFNα and Ribavirin”. The Journal of Infection in Developing Countries, vol. 7, no. 11, Nov. 2013, pp. 859-67, doi:10.3855/jidc.2937.